Vanguard Personalized Indexing Management, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1767306 OAKLAND, CA

Position in PCVX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,470,165

-$273,367 QoQ

Shares Held

25,291

-15.7% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#149

of 329 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 78% Shared 0% None 22%

Healthcare · as of Jun 30, 2026

Vanguard Personalized Indexing Management, LLC holds $97,369,187 across 138 Biotechnology names. PCVX ranks #13 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,151	$21,434,396
2	REGN	Regeneron Pharmaceuticals, Inc.	11,712	$7,302,900
3	INCY	Incyte Corp	34,556	$3,917,268
4	ARGX	Argenx SE	4,103	$3,806,640
5	ALNY	Alnylam Pharmaceuticals, Inc.	11,436	$3,442,579
6	RVMD	Revolution Medicines, Inc.	17,697	$3,314,294
7	MRNA	Moderna, Inc.	43,679	$3,058,840
8	HALO	Halozyme Therapeutics, Inc.	30,414	$2,380,503

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,470,165	25,291	-15.7%	Shares	Sole	2026-08-11
2026-03-31	$1,743,532	30,004	+19.0%	Shares	Sole	2026-05-14
2025-12-31	$1,163,835	25,224	+59.1%	Shares	Sole	2026-02-13
2025-09-30	$571,097	15,855	+24.6%	Shares	Sole	2025-10-31
2025-06-30	$413,592	12,722	+82.6%	Shares	Sole	2025-07-25
2025-03-31	$263,149	6,969	+5.3%	Shares	Sole	2025-05-14
2024-12-31	$541,913	6,620	-1.4%	Shares	Sole	2025-02-10
2024-09-30	$767,437	6,716	+38.5%	Shares	Sole	2024-11-12
2024-06-30	$366,223	4,850	+22.6%	Shares	Sole	2024-08-12
2024-03-31	$270,166	3,955	+19.6%	Shares	Sole	2024-05-09
2023-12-31	$207,679	3,307	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.